Fortem Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
5,778
-761
-12% -$164K 0.3% 74
2026
Q1
$1.42M Buy
6,539
+1,113
+21% +$247K 0.36% 69
2025
Q4
$1.24M Sell
5,426
-724
-12% -$165K 0.33% 72
2025
Q3
$1.42M Sell
6,150
-256
-4% -$52.1K 0.41% 68
2025
Q2
$1.19M Sell
6,406
-1,449
-18% -$269K 0.38% 68
2025
Q1
$1.65M Sell
7,855
-780
-9% -$152K 0.64% 45
2024
Q4
$1.53M Buy
8,635
+126
+1% +$23.2K 0.59% 43
2024
Q3
$1.68M Buy
8,509
+1,362
+19% +$254K 0.68% 38
2024
Q2
$1.23M Buy
7,147
+194
+3% +$32.1K 0.53% 61
2024
Q1
$1.27M Buy
6,953
+1,078
+18% +$186K 0.56% 62
2023
Q4
$910K Sell
5,875
-1,200
-17% -$175K 0.45% 75
2023
Q3
$1.05M Sell
7,075
-1,748
-20% -$257K 0.62% 46
2023
Q2
$1.19M Sell
8,823
-2,516
-22% -$369K 0.7% 44
2023
Q1
$1.81M Sell
11,339
-1,110
-9% -$170K 1.18% 24
2022
Q4
$2.01M Sell
12,449
-48
-0.4% -$7.36K 1.18% 24
2022
Q3
$1.68M Buy
12,497
+655
+6% +$94K 1.16% 20
2022
Q2
$1.81M Buy
11,842
+9,994
+541% +$1.53M 1.19% 17
2022
Q1
$300K Sell
1,848
-1,359
-42% -$197K 0.13% 138
2021
Q4
$434K Sell
3,207
-25
-0.8% -$2.95K 0.2% 121
2021
Q3
$349K Buy
3,232
+25
+0.8% +$2.86K 0.18% 132
2021
Q2
$361K Sell
3,207
-14,363
-82% -$1.62M 0.18% 135
2021
Q1
$1.9M Sell
17,570
-295
-2% -$31.6K 1.1% 22
2020
Q4
$1.91M Buy
17,865
+909
+5% +$87.4K 1.15% 19
2020
Q3
$1.49M Buy
+16,956
New +$1.6M 1.07% 28

Other funds holding ABBV

Fortem Financial Group's ABBV Position: Q2 2026 in Review

Fortem Financial Group reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $164K and leaving 5,778 shares worth $1.45M. The position accounts for 0.3% of the portfolio, ranked #74.

Fortem Financial Group first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.01M in Q4 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fortem Financial Group held 5,778 shares of AbbVie worth $1.45M as of Q2 2026.
  • Fortem Financial Group sold 761 AbbVie shares in Q2 2026, an estimated $164K.
  • AbbVie made up 0.3% of Fortem Financial Group's portfolio in Q2 2026, its #74 holding.
  • Fortem Financial Group first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • Fortem Financial Group's AbbVie position peaked at $2.01M in Q4 2022.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fortem Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.